Two Sigma Securities’s BeOne Medicines Ltd ONC Stock Holding History

Two Sigma Securities’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,656	Closed	-$503K	–	2337
2025 Q4	$503K	Buy	+1,656	New	+$542K	0.07%	389
2025 Q3	–	Sell	-1,984	Closed	-$480K	–	2132
2025 Q2	$480K	Buy	+1,984	New	+$487K	0.06%	453
2024 Q3	–	Sell	-1,660	Closed	-$237K	–	3787
2024 Q2	$237K	Buy	+1,660	New	+$256K	﹤0.01%	2213
2021 Q4	–	Sell	-597	Closed	-$217K	–	2139
2021 Q3	$217K	Sell	597 -146	-20%	-$47.7K	0.01%	1193
2021 Q2	$255K	Sell	743 -502	-40%	-$166K	0.01%	1116
2021 Q1	$433K	Sell	1,245 -66	-5%	-$21.9K	0.02%	322
2020 Q4	$339K	Buy	1,311 +433	+49%	+$119K	0.01%	942
2020 Q3	$251K	Sell	878 -362	-29%	-$85.1K	0.01%	970
2020 Q2	$234K	Buy	+1,240	New	+$202K	0.01%	1040

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Securities's ONC Position: Q1 2026 in Review

Two Sigma Securities sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 1,656 shares — an estimated $503K sold.

Two Sigma Securities first reported a position in ONC in Q2 2020 and held it in 9 quarters. The position peaked at $503K in Q4 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Two Sigma Securities reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 1,656 BeOne Medicines Ltd shares in Q1 2026, an estimated $503K.
Two Sigma Securities first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 9 quarters.
Two Sigma Securities's BeOne Medicines Ltd position peaked at $503K in Q4 2025.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.